Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 26.
Published in final edited form as: Cell Dev Biol. 2013 May 10;2:112. doi: 10.4172/2168-9296.1000112

p53 and the PWWP domain containing effector proteins in chromatin damage repair

Jing Hu 1,2,3, Yanming Wang 1,2,3,*
PMCID: PMC4175562  NIHMSID: NIHMS484454  PMID: 25264544

Abstract

In eukaryotic cells, DNA damage repair occurs on a template DNA that is organized with histones to form nucleosomes and chromatin structures. As such, chromatin plays an important role in DNA damage repair. In this review, we will use “chromatin damage repair” as a framework and highlight recent progress in understanding the role of chromatin, chromatin modifiers, chromatin binding effectors (e.g., the PWWP domain proteins), and the p53 tumor suppressor. We view chromatin as an active participant during DNA damage repair.

Chromatin structure and organization

In eukaryotic cells, the nucleosome is the basic structural unit of chromatin. It is composed of a 147 bp of DNA tightly packed around a core histone octamer, which contains an H3-H4 tetramer and two H2A-H2B heterodimers (Kornberg, 1999; Luger et al., 1997). With the help of about 20 to 60 base pairs of linker DNA, nucleosomes are further packed into an approximately 11-nm “beads-on-a-string” fiber, which defines the first level of chromatin structure (Luger et al., 1997). At the second structural level, 30-nm chromatin fiber is organized by further packing of nucleosome arrays with linker histone H1(Robinson et al., 2006). Furthermore, the chromatin fibers are folded into higher order structures by looping and further folding during interphase. At last, chromatin is further compacted into condensed metaphase chromosome during mitosis.

The interphase chromatin can be divided into two categories due to various degrees of chromatin condensation and composition. While chromatin in a less condensed conformation is termed as euchromatin that is usually related to active transcription, heterochromatin is known as gene-poor region with tightly packed chromatin (Elgin, 1996). Constitutive heterochromatin consists of some structural elements, such as, telomeres, centromeres, non-coding and small repetitive regions. Besides, facultative heterochromatin can be converted from euchromatin due to differentiation, X-chromosome inactivation and so on (Dillon, 2004). Although the mechanism of higher-ordered chromatin structure formation is still not completely clear, it is known that the regulation of chromatin structure dynamics is dependent on many factors, including DNA methylation, histone variants, histone modifications, and binding of non-histone chromatin architectural proteins and protein complexes (Li and Reinberg, 2011). From yeast to human, regulation of eukaryotic chromatin organization has vast significance in regulating many DNA-dependent cellular activities, such as transcription, replication and DNA damage repair. In the following parts, chromatin structure modulation during DNA damage repair in the mammalian system will be further discussed.

DNA damage response signaling network

Genome stability is critical for biological functions and cell viability. However, genome is continuously under threats from various exogenous or endogenous DNA damaging stresses. External ionizing radiation, UV irradiation and environmental chemicals can cause DNA damages. Internal metabolic products, such as reactive oxygen species (ROS), and spontaneous errors during DNA replication alter the genetic information stored in the DNA double helix (Friedberg et al., 2004). These threats cause several types of DNA lesions, including base damages and mismatches, bulky adducts, intra-and inter-strand crosslinks, as well as single and double strand breaks (Postel-Vinay et al., 2012).

To counteract several harmful cellular outcomes of DNA lesions, a defense system called DNA damage response (DDR) follows, which is essential for anti-cancer and anti-aging processes (Diderich et al., 2011). DDR is an integrated network of highly ordered signaling cascades. When facing DNA insults, some protein complexes called “sensors or mediators”, are recruited to DNA damage sites, which can be observed as nuclear foci under microscope. Next, the sensors activate “transducers”, such as a protein kinase ATM/ATR, to transfer and amplify signaling to downstream “effectors”. Many effectors play a key role in deciding the cell fate. In order to survive, cells with transient cell-cycle arrest may resume cell proliferation after successful DNA repair, whereas others may enter permanent cell-cycle arrest and senescence with unrepaired DNA damages. In the worse scenarios, programmed cell death or apoptosis occurs when DNA damage is too severe. Additionally, some other effectors also establish a feedback loop to control the DDR signaling pathways to maintain the homeostasis of cell survival and death after DNA damage (Shiloh and Ziv, 2013; Sulli et al., 2012).

As mentioned above, DNA repair is a crucial mechanism to rescue cells from DNA damage stress. According to the different types of DNA damage produced, there are at least six distinct DNA repair pathways evolved to deal with DNA lesions during DDR: Nucleotide excision repair (NER), base excision repair (BER), mismatch repair, cross-link repair and double-strand break (DSB) repair (Kennedy and D’Andrea). DSB repair can be divided into two different pathways: non-homologous end joining (NHEJ) and homologous recombination (HR) (Chapman et al., 2012).

DNA double-strand break (DSB) is the most lethal type of DNA damage due to a complete breakage of DNA backbone. Nonetheless, the molecular mechanisms described below for DSB repair are also found to participate in DDR initiated by other DNA damage. DSB repair in mammalian cells is a coordinated signaling pathway initiated with immediate activation of the MRN (mre11-rad50-nbs1) complex and the kinase ataxia telangiectasia mutated (ATM). DSB stress-activated ATM kinase phosphorylates H2AX on Ser139 (also called γH2AX) at damage sites. Then, γH2AX spreads along the chromatin up to hundreds of kilobases from initial site with help of the ATM-MRN-MDC1 (mediator of DNA damage checkpoint protein 1) complex (Bonner et al., 2008; Rogakou et al., 1999). This amplified signal recruits massive number of proteins to contribute to the repair process or regulating the cell-cycle checkpoints.

For actual repair, NHEJ is a predominant repair mechanism that directly rejoins the broken DNA ends. Since it utilizes single stranded overhangs at DSB ends, NHEJ can be done at anytime but favored in G1 phase of the cell cycle. Although it is a fast way to response to DSB, NHEJ has higher chance to induce mutagenesis by generating deletions or chromosome translocations. During NHEJ in mammals, Ku70/80 heterodimer with DNA dependent kinase catalytic subunit (DNA-PKcs) bind to DSB site for end tethering, and then recruit Artemis and DNA polymerases μ and λ for gap filling. Finally, ligation step is triggered by DNA ligase IV complex and scaffold proteins, such as X-ray repair cross-complementing protein 4 (XRCC4) and XRCC4-like factor (XLF) (Boboila et al., 2012; Chapman et al., 2012).

Compared to error-prone NHEJ, HR can guarantee high fidelity of repair but require more steps and more protein effectors. Specifically, the MRN complex recognizes DSB sites and generates single-strand DNA intermediates by CtBP-interacting protein (CtIP) mediated resection during HR (Sartori et al., 2007). Replication protein A (RPA), RAD51 and RAD52 bind single-stranded ends, and direct synapsis and strand invasion to the homologous template. The DNA synthesis and ligation are completed finally to restore disrupted genetic information (Misteli and Soutoglou, 2009). Because HR requires homology searching of sister chromatids as accurate template in error-free repair, it only occurs in S and G2 phases (Symington and Gautier, 2011).

Dynamics of chromatin structure regulates DDR

Given that DNA is organized into the chromatin structure, it is not surprising that chromatin structure influences multiple steps during DDR. Usually, less condensed chromatin regions are more sensitive to DNA-damaging agents than those with a higher level of compaction (Costes et al., 2007; Elia and Bradley, 1992). In addition to chromatin’s natural barrier function, the dynamics of chromatin organization affects DDR as well, which was first described in a model termed “access-repair-restore” (ARR) (Figure 1) (Smerdon, 1991; Smerdon et al., 1978). This model elucidates three main steps after DNA damage: (1) the site of damaged chromatin is detected and become more accessible; (2) reorganization of chromatin structure allows processing of DNA repair factors; (3) changes in chromatin organization is restored after repair has finished (Green and Almouzni, 2002; Groth et al., 2007). Previously, the “access” step was always thought that proteins are mainly removed from the chromatin to increase accessibility. Recently, this is renamed as the “prime” step, which involves both adding-in and taking-out of chromatin factors at this initial stage of DDR (Soria et al., 2012).

Figure 1. Chromatin structure alterations in the ARR model.

Figure 1

According to the ARR model, when DNA double-strand breaks occur, conformational changes in chromatin allow the DNA repair machineries to access, repair, and restore the chromatin structures. At the “access” step, DNA damage sites are sensed and labeled with histone modifications as damage markers. The chromatin around breakage points becomes less condensed via nucleosomes sliding or eviction, which provides accessibility for DNA repair machinery. At the “repair” step, damage signaling of histone modifications spreads and maintains along the chromatin. DNA damage is repaired by NHEJ or HR. At the “restore” step, histone markers are removed, new histones are deposited, and the chromatin structure is resumed to pre-damage state. Many chromatin regulation mechanisms are involved, such as chromatin modifiers, ATP-dependent remodelers and ATP-independent histone chaperones.

In general, there are three major mechanisms involved in the regulation of nucleosome/chromatin organization: post-translational histone modifications, ATP-dependent chromatin remodeling, and ATP-independent chromatin modulation (Polo and Jackson, 2011). These three types of machineries function in coordinated manner throughout the ARR process of DNA damage repair.

1. Post-translational histone modifications

Diverse post-translational modifications, such as methylation, acetylation, phosphorylation, citrullination, ubiquitylation, SUMOylation and poly ADP-ribosylation, preferentially occur at histone tails (Kouzarides, 2002; Kuo and Allis, 1998; Nathan et al., 2006; Nowak and Corces, 2004; Wang et al., 2004; Ziegler, 2000). These histone modifications could alter chromatin structure, by changing histone-DNA and histone-histone contacts or recruiting different chromatin factors (Fischer et al., 2008). It has been proposed that covalent histone modifications work sequentially or in combination to form a “histone code” and define various downstream biological outcomes like DNA transcription, replication and repair (Jenuwein and Allis, 2001). Recently, more and more published work indicates that DSB repair is a new hot target to decipher stepwise DNA-damage-induced histone code (Lukas et al., 2011).

1A. Poly ADP-ribosylation

As the earliest modification detected at DNA damage sites, poly ADP-ribosylation is produced by poly ADP-ribose polymerases (PARP) and erased by poly ADP-ribose glycohydrolase (PARG) (Ciccia and Elledge, 2010; Krishnakumar and Kraus, 2010). NuRD (nucleosome remodeling and deacetylase) and Polycomb complexes are recruited to poly ADP-ribose (PAR) chains at lysine residues within the N-terminal tail of histones. These chromatin regulators help to temporarily form condensed repressive chromatin, inhibiting any possible DNA breakage from RNA polymerase interruption and further transcription (Chou et al., 2010). Intriguingly, chromatin at DSB site also has an increased accessibility by association with ATPase motor containing chromatin remodeler complexes (e.g. ALC1, amplified in liver cancer 1) in PAR-dependent manner (Ahel et al., 2009). Thus, poly ADP-ribosylation perhaps performs a critical role in immediate damage sensing and pilots downstream DDR events.

1B. Phosphorylation

Phosphorylation of H2AX Ser139 (γH2AX) was first discovered in 1998 and serves as a primary marker of DDR signaling activation (Rogakou et al., 1998). The histone H2AX variant exists in different cell lines with genomic occupancy ranging from 2% to 20% of the total amount of H2A (Rogakou et al., 1998). A ChIP-seq analysis shows that the distribution of H2AX is enriched at euchromatin regions other than heterochromatin (Iacovoni et al., 2010). Moreover, H2AX knockout mice are more sensitive to ionizing radiation and show defects in DNA repair and genome integrity maintenance (Celeste et al., 2002).

As mentioned before, the MRN complex binds to DSB sites, recruits and activates ATM (Lavin 2008). ATM in turn induces γH2AX, providing a binding site for MDC1 (Lou et al., 2006; Matsuoka et al., 2007; Stucki et al., 2005). The MDC1 protein docks more ATM-MRN complexes to promote the propagation of γH2AX markers from the original break points to a region that could be as far as 2 megabases away (Bonner et al., 2008; Chapman and Jackson, 2008; Rogakou et al., 1999). Using 2D and 3D confocal microscopy and ChIP analyses, it is revealed that γH2AX shows high densities near DSB sites and weaker signals at distant sites (Savic et al., 2009a). Although the mechanism underlying γH2AX expansion is not fully understood, it is known that nuclear diffused ATM may trigger long-distance γH2AX formation via MDC1-independent manner during V(D)J recombination in pre-B cells (Savic et al., 2009b). In addition to MDC1, BRIT1/MCPH1 (microcephalin) was identified as a docking protein to recognize γH2AX (Wood et al., 2007). It can recruit SWI-SNF chromatin remodeling complex to enhance chromatin accessibility (Peng et al., 2009).

At the final “restore” stage, γH2AX must be removed to resume previous local chromatin status. Several protein phosphatases such as PP2A, PP4 and PP6 have been discovered to target γH2AX (Chowdhury et al., 2005; Chowdhury et al., 2008; Douglas et al., 2010). WIP1 was a recently identified enzyme to dephosphorylate not only γH2AX but also some other ATM/ATR substrates (Moon et al., 2010). Since wild-type p53-induced phosphatase 1 (WIP1) is upregulated by p53, there is a p53-mediated feedback loop to restrain DNA damage signal amplification by an increase in γ2AX phosphorylation levels.

In addition to γH2AX, phosphorylation of H2AX Tyr142 serves as an important marker for undamaged status of the whole genome. The phosphorylation of this adjacent site to Ser139 is constitutively maintained by Williams syndrome transcription factor (WSTF) under unstressed conditions, and then is removed by eye absent homologue 1/3 (EYA 1/3), accompanied with γH2AX generation (Cook et al., 2009; Xiao et al., 2009). This conserved phosphorylation of H2AX is also important in cell fate decisions in concert with γH2AX.

1C. Acetylation

Histone H4 acetylation is important in forming chromatin structure related to active transcription (Campos and Reinberg, 2009). Especially, acetylated H4 Lys16 can perturb the ionic interaction between the N-terminal tail of histone H4 and H2A-H2B dimer of an adjacent nucleosome to prohibit further package of the 30 nm chromatin fiber (Luger et al., 2012; Robinson et al., 2008). After binding to chromatin via γH2AX-dependent manner, the docking protein MDC1 rapidly recruits a multiple subunit histone acetyltransferase (HAT) complex, NuA4, whose Tip60 subunit acetylates H4K16 (Sun et al., 2005). Similar to γH2AX, H4 acetylation also spreads out from DSB sites to a region as far as hundreds of kilobases away. Disruption of Tip60 activity can abolish H4K16 acetylation and promote compaction of chromatin (Murr et al., 2006). Conversely, H4K16 acetylation can be removed by histone deacetylases, HDAC1/2, which may prevent Ku complex sliding and dissociation from DNA ends especially in NHEJ pathway (Miller et al., 2010).

1D. Ubiquitination

Besides the NuA4 complex, MDC1 also serves as a platform for sequential recruitment of ubiquitin ligases RNF8 and RNF168 (Ikura et al., 2007). On one hand, the RNF8-RNF168 cascade triggers ubiquitination of H2A, H2AX and H2B for chromatin structure relaxation. On the other hand, the ubiquitination is required for binding of other chromatin factors such as breast cancer type 1 susceptibility protein (BRCA1) and p53 binding protein 1 (53BP1) (Doil et al., 2009; Kolas et al., 2007). Additionally, H2B mono-ubiquitination mediated by RNF20-RNF40 heterodimer directly leads to chromatin decompaction at DSB sites (Moyal et al., 2011).

1E. Methylation

Similar to ubiquitination, histone Lys methylation facilitates recruitment of repair factors during DDR. The tudor domain of 53BP1 recognizes H3K79me2, a methylation site that is normally embedded within the body of nucleosomes and becomes exposed upon DNA damage mediated conformational changes (Huyen et al., 2004). Furthermore, the interaction between 53BP1 and H4K20me2 is enhanced by DSB (Botuyan et al., 2006). Interestingly, to maintain genome integrity, a quite high level of H4K20me2 (>80%) is constitutively present. After DSB, H4K20me2 may be further exposed, or established from unmodified histone H4 with de novo methylation by a methyltransferase MMSET (Pei et al., 2011; Schotta et al., 2008). This increasing H4K20me2 level is crucial for 53BP1 recruitment and a cascade of downstream regulatory events.

2. ATP-dependent chromatin remodeling

Besides covalent histone modifications, ATP-dependent chromatin remodeling is another important mechanism for chromatin reorganization. Chromatin remodelers utilize ATP hydrolysis to affect chromatin structure by either replacing histones with corresponding variants, or repositioning (sliding or removal) of nucleosomes (Price and D’Andrea, 2013). At least three remodeler families have been found to play a role during DSB repair in mammals: Swr1-like, Snf2-like and Rad54-like families (Seeber et al., 2013). And these chromatin remodelers regulate different stages of DSB repair. For example, ION80 complex, a member of Swr1-like family, is recruited to DSB sites by its ARP8 subunit, and facilitates H2AX phosphorylation expansion by its ARP5 subunit at the “access” step (Kashiwaba et al., 2010; Kitayama et al., 2009). Another example is the human NuA4 complex, which contains Tip60 acetyltransferase and the p400 ATPase motor protein. Once DSB stress occurs, histone H2A is replaced with H2A.Z variant by p400, and H4K16 acetylation is triggered by the TRRAP-Tip60 subunits. Both events result in the formation of relaxed chromatin (Xu et al., 2012).

3. ATP-independent chromatin modulation

Histone chaperones are histone-binding proteins that contribute to both assembly and disassembly of nucleosomes without using the ATP energy. Given their roles in chromatin structure regulation, it is anticipated that histone chaperones are involved in ARR as well. The FACT (facilitating chromatin transcription) complex is a heterodimer of Spt16 and SSRP1 (structure specific recognition protein-1), which is known in the regulation of transcription elongation (Belotserkovskaya and Reinberg, 2004; Orphanides et al., 1998). Its function is inhibited by PARP1 mediated poly ADP-ribosylation during “repair” (Kraus, 2008). At the “restore” step, however, FACT complex replaces γ2AX-H2B with unmodified H2AX-H2B or H2A-H2B dimers thereby facilitating the removal of DNA damage markers (Heo et al., 2008). In addition, Asf1 (anti-silencing function 1) and CAF-1 (chromatin assembly factor 1) synergize to exchange histones H3/H4 with newly synthesized H3/H4 during the “restore” step. The newly synthesized histone H3 is acetylated at Lys56, a modification important for the nucleosome reassembly process. However, it is rapidly removed by HDACs (hSIRT2/3) to allow chromatin condensation (Mello et al., 2002; Vempati et al., 2010). It is still unknown whether histone chaperones capture displaced histones during the initial “access” step (Avvakumov et al., 2011).

In sum, histone modifications, ATP-dependent and -independent chromatin mechanisms play important roles at all steps of DDR. The crosstalk among these mechanisms is indispensable to trigger spatially and temporally coordinated events for DNA damage repair (Figure 1).

PWWP domain-containing proteins are involved in DDR

Despite of the primary regulatory machinery of chromatin described above, some chromatin-associated proteins also serve as effectors to modulate DNA damage pathways. The PWWP domain containing proteins were recently found to play important roles in DDR (Table 1). In the following section, we will further discuss the role of this family of proteins serving as chromatin binding factors and DDR effectors.

Table 1.

The role of the PWWP domain proteins in DNA damage response

Effectors Homologs PWWP domain Histone methylation recognition Histone modifier activity DNA damage stimuli Role in DNA damage repair Role in DDR
Pdp1 Fission yeast Residue 52–114 H4K20me Not found UV, ionizing radiation Yes Set9 recruitment (damage signaling transduction)
MUM1/EXPAND1 Human, mouse, rat, bovine Residue 411–472 Not found Not found Ionizing radiation, neocarzinostatin Yes Recruited by 53BP1; chromatin relaxation (NHEJ repair)
MMSET (WHSC1) Human, mouse Residue 222–286; residue 880–942 H4K20me Methylate H4K20 Ionizing radiation Yes 53BP1 recruitment (damage signaling transduction)
LEDGF (PSIP1/p75) Human, mouse, rat, bovine Residue 1–63 H3K36me3 (PSIP1/p52) Not found Ionizing radiation, camptothecin, mitomycin C Yes CtIP recruitment (HR repair)

1. The PWWP domain in DNA and methyl-histone binding

The PWWP domain is a member of the “Royal family” protein domains, including the PWWP-, Tudor-, chromo- and MBT-domains (Maurer-Stroh et al., 2003). The PWWP domain features a conserved Pro-Trp-Trp-Pro core motif. It was firstly identified in the Wolf-Hirschhorn syndrome candidate 1 (WHSC1) protein and was predicted to mediate protein-protein and protein-DNA interactions (Stec et al., 1998). So far, there are more than 60 proteins that have been discovered to have PWWP domain (Stec et al., 2000). Since PWWP domain shares significant sequence similarity with Tudor domain and other members, it was postulated to recognize methylated histone residues (Maurer-Stroh et al., 2003). The bromodomain and PHD finger-containing protein 1 (BRPF1) binds to a histone H3K36me3 peptide using its PWWP domain (Vezzoli et al., 2010). Recently, the Dr. Min’s group systematically studied several representative human PWWP domains in biochemical and crystallization studies (Wu et al., 2011). A typical PWWP domain has three structural motifs: a N-terminal β-barrel, an insertion between the second and the third β-strands, and a C-terminal α-helix bundle (Wu et al., 2011). The PWWP domain recognizes histone Lys methylation with an aromatic cage (Wu et al., 2011). Meanwhile, the PWWP domain is also known as a non-specific DNA-binding module due to its DNA-interacting surface with basic electrostatic features. It is reported that the PWWP domain of DNA methyltransferase Dnmt3b targets the enzyme to pericentric heterochromatin (Chen et al., 2004). The PWWP domain of mutS homolog 6 (MSH6), is another example showing affinity to double stranded DNA during DNA mismatch repair (Laguri et al., 2008).

2. The HRP subfamily of PWWP-domain containing proteins

The hepatoma-derived growth factor (HDGF) is a nuclear protein, which was initially identified as a protein with mitogenic activity (Everett et al., 2001; Kishima et al., 2002). HDGF and other HDGF-related proteins (HRPs), including HDGF-related proteins HRP-1, -2, -3, -4 and lens epithelium-derived growth factor (LEDGF) form a subfamily of proteins that contains the PWWP domain. Members of HRP subfamily share a highly conserved N-terminal region containing the PW(H)WP domain but differ from their diverse C-termini.

As a prototype protein of this family, HDGF is highly expressed in certain tissues during development (Everett, 2001), and the over-expression of HDGF was detected in many human cancers (Okuda et al., 2003). HDGF protein interacts with C-terminal binding protein (CtBP) via a “PKDLF” motif within the PWWP domain to repress the SET and MYND domain containing 1 (SMYD1) gene expression (Yang and Everett, 2009). Although most PWWP domain-containing proteins bind to DNA via non-specific manner, it is found that HDGF associates with a 37 bp DNA showing certain degree of sequence conservation on the SMYD1 promoter through its PWWP domain (Yang and Everett, 2007). LEDGF is the alternative splicing isoform p75 of PC4 and SF2 interacting protein 1 (Psip1) (Singh et al., 2000). It consists of a N-terminal PWWP domain, an AT hook-like motif and a C-terminal HIV integrase binding domain (IBD) (Cherepanov et al., 2005; Vanegas et al., 2005). LEDGF can bind to HIV-1 integrase via its IBD. This prevents HIV-1 integrase from degradation by proteasome, and bridges viral genome integration to the host genome (Llano et al., 2004; Maertens et al., 2003). LEDGF is also shown to bind to MLL (myeloid/lymphoid or mixed-lineage leukemia), an H3K4 methyltransferase, via Menin in transformed myeloid progenitors (Yokoyama and Cleary, 2008). A short splicing isoform p52 of Psip1 is able to recognize H3K36me3 specifically via its PWWP domain and regulates alternative splicing (Pradeepa et al., 2012). Furthermore, HDGF2 (alias of HRP-2), which also contains a C-terminal IBD, plays an accessory role in LEDGF-mediated HIV integration (Wang et al., 2012). Although extensive literature documents studied the potential biological function of HDGF and LEDGF, biological functions of HDGF2 and other members of this protein family remain still largely unknown.

3. PWWP domain-containing proteins in DDR

The PWWP domain-containing proteins function as chromatin-associated factors and contribute to various biological events using DNA as a template, such as transcription and DNA replication. How the PWWP domain-containing proteins are involved in DNA repair process is a field of increasing interest. Four proteins with PWWP domain were shown to regulate DDR at various steps.

The PWWP domain-containing protein (Pdp1) protein in fission yeast is a PWWP protein with no clear homologous protein found in higher eukaryotes (Wang et al., 2009). Pdp1 prefers to recognize H4K20me1 via its PWWP domain and facilitates histone methyltransferase Set9 to further produce di- and tri-methylation of H4K20. Pdp1 is also critical for Crb2 (53BP1 homologous in yeast) accumulation and phosphorylation under DNA damage stress (Wang et al., 2009). Depletion of Pdp1 disrupts DNA repair pathway and makes yeast more sensitive to DNA damage treatment (Wang et al., 2009). Moreover, the Pdp1 PWWP domain was found to bind both H4K20me3 peptides and double-strand DNA fragments simultaneously in biochemical and crystal studies (Qiu et al., 2012).

The human melanoma associated antigen mutated 1 (MUM1/EXPAND1) shares homology with proteins in mammals (mouse, rat and bovine) (Huen et al., 2010; Sy et al., 2010). The PWWP domain of EXPAND1 locates at its C-terminal region. Although no histone methylation binding affinity has been found yet, EXPAND1 is a chromatin-bound factor recruited to damage sites by interacting with 53BP1 and enhances further chromatin decondensation upon DNA damage stress (Huen et al., 2010; Sy et al., 2010).

MMSET (also called WHSC1 or NSD2) containing a SET domain, has been studied to generate several histone methylations (H3K4me3, H3K27me3, H3K36me2, H3K36me3) and regulate transcription (Kim et al., 2008; Kuo et al., 2011; Li et al., 2009; Marango et al., 2008; Nimura et al., 2009). However, its function in DNA repair regulation was discovered only recently (Pei et al., 2011). MMSET is phosphorylated by ATM and then accumulated at DNA damage sites depending on the H2AX-MDC1 protein complex. As a SET domain-containing histone methyltransferase that harbors a PWWP domain, MMSET induces di and tri-methylation of H4K20 accumulated at DSB sites and facilitates recruitment of 53BP1 (Pei et al., 2011). Strikingly, MMSET seems to mediate crosstalk among multiple modifications, including phosphorylation, ubiquitination and methylation, during DDR (Pei et al., 2011).

Recently, the Jäättelä group reported that LEDGF (Psip1/p75) plays an important role in DSB repair in addition to its well-known functions, such as promoting HIV integration and modulating alternative splicing (Daugaard et al., 2012). LEDGF helps to defend genotoxicity and protect survival of cells under DNA damage by enhancing the recruitment of CtIP at DNA break sites especially (Daugaard et al., 2012). Deficiency in LEDGF results in impaired DNA end resection during HR repair.

To sum up, these PWWP proteins bind to chromatin and maintain genome stability in physiological conditions. Once DNA damage occurs, they react immediately to promote recruitment of DNA repair factors like 53BP1 and CtIP, and regulate chromatin condensation during DDR signaling (Table 1). It is anticipated the underlying correlation between the PWWP domain and DNA repair mechanism will be studied further with more identified PWWP proteins.

p53 is a key effector after the initiation stage of DDR

Unlike less-characterized PWWP proteins, p53 is much more versatile as a “molecular node” that effects in multiple facets of DDR (Sengupta and Harris, 2005; Vogelstein et al., 2000). p53 was first discovered as an oncogene in 1979, but was later recognized as a tumor suppressor protein at the hub of an intriguing signaling network in mammalian cells (Baker et al., 1989; Finlay et al., 1989; Linzer and Levine, 1979). Structural studies found that p53 contains an N-terminal transactivation and proline-rich domain (residues 1–92), a DNA binding domain (residues 100–300), a tetramerization domain (residues 307–355), and a C-terminal regulatory domain (residues 356–393) (Kruse and Gu, 2009). It is reported that p53 gene is altered in more than 50% of human cancers, and the mutations predominantly occur within its conserved DNA binding domain (Harris and Hollstein, 1993; Hollstein et al., 1994). Since tumor development always leads to accumulation of genetic DNA lesions, p53 plays a very critical role in guarding genome stability in DDR and preventing tumorigenesis (Hahn and Weinberg, 2002; Levine, 1997).

1. Activation of p53 upon DNA damage stress

Under unstressed conditions, murine double minute 2 homolog (MDM2) exerts E3 ubiquitin-protein ligase activity to ubiquitinate p53. p53 upregulates MDM2 transcription to establish a negative feedback loop (Brooks and Gu, 2006; Wu et al., 1993). In addition, MDM4 (also known as MDMX) is identified in a heterodimer with MDM2 to facilitate p53 ubiquitination, and MDM4 alone can repress p53-mediated transcription (Francoz et al., 2006; Sharp et al., 1999). p53 turnover is also controlled by other proteins such as DAXX (death-domain associated protein) and HAUSP (herpersvirus-associated ubiquitin-specific protease), which reduce MDM2 auto-ubiquitination and further enhance p53 degradation (Li et al., 2004; Tang et al., 2006a). In this way, p53 is kept at very low levels in a latent form in cells without DNA damage stress (Haupt et al., 1997; Lee and Gu, 2010; Sharp et al., 1999).

When DNA damage stimuli are detected, activation of p53 can be achieved by several steps (Figure 2) (Kruse and Gu, 2009). First, p53 is stabilized by decreasing its ubiquitination mediated by the MDM2 pathway. The phosphoatidylinositol-3 kinase-like kinase family members, ATM and ATR (ataxia-telangiectasia and Rad3-related) phosphorylate MDM2 and disrupt MDM2-DAXX-HAUSP complex thereby inducing p53 accumulation by preventing its ubiquitination (Meulmeester et al., 2005).

Figure 2. The role of p53 in DNA damage repair and cell fate determination.

Figure 2

DNA damage stress activates kinases, such as ATM, ATR, Chk1/2, which stabilize and release p53 from its negative regulator the MDM2 protein complex. Activated p53 are further modified by various modifications, including phosphorylation, acetylation, methylation, etc. Modified p53 triggers cells to undergo cell-cycle arrest, either to proliferation after successful DNA repair or senescence without repair. Moreover, p53 can lead to apoptosis when the chromatin damage is too severe.

Accumulated p53 is further modified to its active form with multiple post-translational modifications. Overlapping with the stabilization step, ATM, ATR and DNA-PK kinases phosphorylate Ser15 of p53 (Banin et al., 1998; Canman et al., 1998; Lakin et al., 1999; Shieh et al., 1997). Thr18 of p53 is phosphorylated by casein kinase 1 (CK1) (Dumaz et al., 1999). The checkpoint kinase 1/2 (Chk1/2), which are the substrates of ATM and ATR, phosphorylate Ser20 of p53 (Shieh et al., 2000). These key phosphorylation sites within transactivation domain are crucial for the dissociation of p53 from MDM2/MDM4, and guide a range of modifications in an intricate but ordered way. The covalent modifications tailor p53 with enhanced activities in DNA binding ability, tetramerization and gene activation. For example, the HAT p300/CBP, which is recruited to p53 after S15/37 phosphorylation, acetylates lysine residues 373 and 382 at the C-terminal regulatory domain to increase the association of p53 to the p21 promoter region (Sakaguchi et al., 1998). In addition, acetylation of K120 and K164 within DNA-binding domain by HATs MOF/Tip60 and p300/CBP, respectively, promotes specific binding of p53 to the p21 and PUMA promoters (Tang et al., 2006b; Tang et al., 2008). Further, methylation of p53 at C-terminal residue K372 contributes to the p21 gene activation by increasing the affinity between p53 and the p21 promoter (Chuikov et al., 2004). After these activation steps, p53 binds to its target genes with specific recognition elements and recruits various cofactors to fine-tune transcription, which may lead to diverse downstream events such as cell-cycle arrest, apoptosis and DNA repair (Figure 2) (Meek, 2009).

Interestingly, p53 can recognize DNA fragments via non-specific manner to participate in DNA repair process (Liu and Kulesz-Martin, 2001). Moreover, p53 itself may translocate to cytoplasm and facilitate transcription-independent apoptosis (Green and Kroemer, 2009). Since the different roles of p53 are important in deciding different cellular outcomes, it will be discussed with more details in the following paragraphs.

2. p53-mediated pathways with different cell fates

As a cellular gatekeeper, p53 is always accountable for answering the question about “to be or not to be”, i.e., the choice between to live or to die after DNA damages (Levine, 1997).

2A. Cell-cycle arrest

Upon activation by DNA damages, p53 serves as a transcriptional factor to regulate the expression of genes involved in the cell-cycle arrest. The cell cycle includes four distinct stages, the G1, S, G2 and M phases. Multiple checkpoints are involved in the whole cell cycle to guarantee the accuracy of the cell division (Giono and Manfredi, 2006). The G1/S checkpoint blocks DNA synthesis if DNA damage is detected. If there is no DNA damage present, several cyclin/cdk complexes sequentially work to phosphorylate the tumor suppressor pRb, leading to the dissociation of transcription factor E2F from pRb and the activation of genes important for DNA replication initiation (Sherr, 1994). p53 controls the G1/S cell cycle arrest by activating p21, which inhibits cyclin E/cdk2 and cyclin A/cdk2 complexes (Harper et al., 1993).

Another important DNA damage checkpoint occurs at the G2/M phase transition. The cyclin B/cdc2 complex is the main target for the G2/M phase checkpoint. p53 upregulates p21 and GADD45, which in turn induce the dissociation of cdc2 from cyclin B (Dulic et al., 1998; Zhan et al., 1999). 14-3-3σ another p53 target, promotes sequestration of cdc2 complex in cytoplasm (Lin et al., 1992; Lopez-Girona et al., 2001). Meanwhile, p53 can directly repress Cdc25C, which dephosphorylates the cdc2 complex for activation (St Clair et al., 2004). In sum, p53 maintains cell cycle arrest by regulating its target genes related to the DNA damage checkpoints at the G1/S and G2/M transitions. On the other hand, p53-dificient cells have failures in pausing at the S phase and mitosis checkpoints (Andreassen et al., 2001; Brown et al., 1994; Prives and Manfredi, 2005; Zhu et al., 2004).

2B. DNA damage repair

Since cell-cycle checkpoints always postpone progression of the cell cycle under DNA damage conditions, it is considered as a surveillance mechanism to allow enough time for DNA repair. Although p53 is not a primary sensor of DNA damage stresses, it functions as a critical effector through transcriptional regulation or association with certain DNA repair factors. At the p53-depenent transcription aspect, xeroderma pigmentosum group C (XPC) is a p53 target gene and the protein senses pyrimidine dimers and recruits TFIIH complex to the DNA damage sites during NER (Adimoolam and Ford, 2002; Ng et al., 2003; Sugasawa et al., 2005). As mentioned before, p53 transactivates WIP1, which can remove DNA damage marker γH2AX to restore the chromatin to pre-damage status (Moon et al., 2010). In addition, p53 is able to directly interact with some proteins involved in DNA repair. For example, p53 dimethylated at K370 and K382 after DNA damage has higher affinity to 53BP1, which may enhance the involvement of p53 during the repair process (Huang et al., 2007). More strikingly in HR repair, p53 can inhibit heteroduplex formation mediated by RAD51 due to their direct association (Buchhop et al., 1997; Linke et al., 2003; Yoon et al., 2004). p53 is found to recognize several DNA structures including single-strand DNA, DSB ends, DNA with holiday junctions, DNA duplex with insertion-deletion-lesion mismatches, DNA with single-stranded gap, and triple-stranded DNA (Liu and Kulesz-Martin, 2001). These DNA structures usually appear as the intermediates of DNA damage and repair, and associate with p53 via non-specific sequence binding manners (Liu and Kulesz-Martin, 2001). Additionally, p53 is reported to facilitate reannealing and end-joining at DNA damage sites during NHEJ (Bill et al., 1997; Tang et al., 1999). However, the direct roles of p53 in these damaged DNA structures are yet to be explored.

2C. Apoptosis

When DNA repair machinery is helpless to recover from extensive DNA damages, p53 triggers apoptosis via transcription-dependent or –independent pathways, to terminate those cells that may do damage to the whole organism. On one hand, p53 is known to induce expression of pro-apoptotic genes, such as PUMA (p53 upregulated modulator of apoptosis), BAX (Bcl2-associated protein X), and BAK (Bcl-2 antagonist/killer) (Kim et al., 2009; Selvakumaran et al., 1994; Yu et al., 2001). PUMA and some other factors lead to the release of BAX and BAK from anti-apoptotic proteins. Activated BAX and BAK then increase the permeability of mitochondria membrane, and induce cytochrome c release and apoptosis (Griffiths et al., 1999; Wei et al., 2001). On the other hand, p53 itself can be targeted to and accumulate in mitochondria for apoptosis (Chipuk et al., 2004; Leu et al., 2004). The p53R72 polymorphism has been shown to have greater ability in mitochondria localization and apoptosis induction than the p53P72 allele (Dumont et al., 2003). Although there is no mitochondria-targeting sequence identified in p53, some references reveal that Tid1 (tumorous imaginal discs 1) or OKL38 (ovary, kidney and liver protein 38) may help to regulate p53 mitochondrial translocation (Ahn et al., 2010; Hu et al., 2012).

In short, p53 functions as a “ cellular rheostat” (Sengupta and Harris, 2005), which can receive and gauge the upstream signals, transfer them to downstream effectors with more specific cellular functions leading cells to their unique fates and destinations (Figure 2).

Summary and Perspectives

The DNA damage response signaling cascade is initiated by detection of DNA breakage sites (Figure 3). The sensors pass the damage messages to transducers that are mainly kinases, which pass on the signals to modulate chromatin structures by many factors, such as histone modification enzymes, chromatin remodelers, histone chaperones. The altered chromatin structure facilitates and coordinates many events critical for repair of the damaged chromatin. Chromatin binding proteins, such as the PWWP domain containing proteins, are effectors recruited to the DNA damage sites to facilitate the repairing process. However, these proteins can further crosstalk with the chromatin modifiers via feedback loops to reinforce the function of the DNA damage repair machineries. Furthermore, the p53 tumor suppressor can regulate the expression of downstream target genes to determine the cellular outcomes after DNA damage, including cell cycle arrest, senescence or apoptosis. It is notable that cytoplasmic p53 plays a direct role in apoptosis via a mitochondrial mediated pathway. In sum, chromatin maybe viewed to play a pivotal role in organizing the entire DNA damage response and facilitating the cellular fate determination after DNA damages.

Figure 3. Chromatin associated proteins can serve as the DNA damage signal sensors, transducers, and effectors.

Figure 3

See text for further discussion.

Acknowledgments

The author thanks members of the Wang lab as well as the Center for Eukaryotic Gene Regulation for helpful discussions. We thank Dr. Kuangyu Yen for critical reading of this review. Jing Hu is partially supported by the BMMB graduate program. Research in the Wang lab is supported by NIH R01 CA136856 to Y.W.

Abbreviations

ARR

access-repair-restore

ATM

ataxia telangiectasia mutated

DDR

DNA damage response

DSB

DNA double-strand break

HAT

histone acetyltransferase

HR

homologous recombination

HRP

hepatoma-derived growth factor related protein

MDC1

mediator of DNA damage checkpoint protein 1

MRN

mre11-rad50-nbs1

NER

nucleotide excision repair

NHEJ

non-homologous end joining

53BP1

p53 binding protein 1

γH2AX

phosphorylation of H2AX Ser139

References

  1. Adimoolam S, Ford JM. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:12985–12990. doi: 10.1073/pnas.202485699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science. 2009;325:1240–1243. doi: 10.1126/science.1177321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahn BY, Trinh DL, Zajchowski LD, Lee B, Elwi AN, Kim SW. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene. 2010;29:1155–1166. doi: 10.1038/onc.2009.413. [DOI] [PubMed] [Google Scholar]
  4. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Molecular biology of the cell. 2001;12:1315–1328. doi: 10.1091/mbc.12.5.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Avvakumov N, Nourani A, Cote J. Histone chaperones: modulators of chromatin marks. Molecular cell. 2011;41:502–514. doi: 10.1016/j.molcel.2011.02.013. [DOI] [PubMed] [Google Scholar]
  6. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244:217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  7. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998;281:1674–1677. doi: 10.1126/science.281.5383.1674. [DOI] [PubMed] [Google Scholar]
  8. Belotserkovskaya R, Reinberg D. Facts about FACT and transcript elongation through chromatin. Current opinion in genetics & development. 2004;14:139–146. doi: 10.1016/j.gde.2004.02.004. [DOI] [PubMed] [Google Scholar]
  9. Bill CA, Yu Y, Miselis NR, Little JB, Nickoloff JA. A role for p53 in DNA end rejoining by human cell extracts. Mutation research. 1997;385:21–29. doi: 10.1016/s0921-8777(97)00040-2. [DOI] [PubMed] [Google Scholar]
  10. Boboila C, Alt FW, Schwer B. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Advances in immunology. 2012;116:1–49. doi: 10.1016/B978-0-12-394300-2.00001-6. [DOI] [PubMed] [Google Scholar]
  11. Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. GammaH2AX and cancer. Nature reviews Cancer. 2008;8:957–967. doi: 10.1038/nrc2523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Botuyan MV, Lee J, Ward IM, Kim JE, Thompson JR, Chen J, Mer G. Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair. Cell. 2006;127:1361–1373. doi: 10.1016/j.cell.2006.10.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brooks CL, Gu W. p53 ubiquitination: Mdm2 and beyond. Molecular cell. 2006;21:307–315. doi: 10.1016/j.molcel.2006.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Brown CR, Doxsey SJ, White E, Welch WJ. Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes. Journal of cellular physiology. 1994;160:47–60. doi: 10.1002/jcp.1041600107. [DOI] [PubMed] [Google Scholar]
  15. Buchhop S, Gibson MK, Wang XW, Wagner P, Sturzbecher HW, Harris CC. Interaction of p53 with the human Rad51 protein. Nucleic acids research. 1997;25:3868–3874. doi: 10.1093/nar/25.19.3868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Campos EI, Reinberg D. Histones: annotating chromatin. Annual review of genetics. 2009;43:559–599. doi: 10.1146/annurev.genet.032608.103928. [DOI] [PubMed] [Google Scholar]
  17. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 1998;281:1677–1679. doi: 10.1126/science.281.5383.1677. [DOI] [PubMed] [Google Scholar]
  18. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, et al. Genomic instability in mice lacking histone H2AX. Science. 2002;296:922–927. doi: 10.1126/science.1069398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chapman JR, Jackson SP. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO reports. 2008;9:795–801. doi: 10.1038/embor.2008.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Molecular cell. 2012;47:497–510. doi: 10.1016/j.molcel.2012.07.029. [DOI] [PubMed] [Google Scholar]
  21. Chen T, Tsujimoto N, Li E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol Cell Biol. 2004;24:9048–9058. doi: 10.1128/MCB.24.20.9048-9058.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, Engelman A. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc Natl Acad Sci U S A. 2005;102:17308–17313. doi: 10.1073/pnas.0506924102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 2004;303:1010–1014. doi: 10.1126/science.1092734. [DOI] [PubMed] [Google Scholar]
  24. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:18475–18480. doi: 10.1073/pnas.1012946107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Molecular cell. 2005;20:801–809. doi: 10.1016/j.molcel.2005.10.003. [DOI] [PubMed] [Google Scholar]
  26. Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, Dykxhoorn DM, Weinstock DM, Pfeifer GP, Lieberman J. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Molecular cell. 2008;31:33–46. doi: 10.1016/j.molcel.2008.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, et al. Regulation of p53 activity through lysine methylation. Nature. 2004;432:353–360. doi: 10.1038/nature03117. [DOI] [PubMed] [Google Scholar]
  28. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Molecular cell. 2010;40:179–204. doi: 10.1016/j.molcel.2010.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature. 2009;458:591–596. doi: 10.1038/nature07849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Costes SV, Ponomarev A, Chen JL, Nguyen D, Cucinotta FA, Barcellos-Hoff MH. Image-based modeling reveals dynamic redistribution of DNA damage into nuclear sub-domains. PLoS computational biology. 2007;3:e155. doi: 10.1371/journal.pcbi.0030155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Daugaard M, Baude A, Fugger K, Povlsen LK, Beck H, Sorensen CS, Petersen NH, Sorensen PH, Lukas C, Bartek J, et al. LEDGF (p75) promotes DNA-end resection and homologous recombination. Nat Struct Mol Biol. 2012;19:803–810. doi: 10.1038/nsmb.2314. [DOI] [PubMed] [Google Scholar]
  32. Diderich K, Alanazi M, Hoeijmakers JH. Premature aging and cancer in nucleotide excision repair-disorders. DNA repair. 2011;10:772–780. doi: 10.1016/j.dnarep.2011.04.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Dillon N. Heterochromatin structure and function. Biology of the cell/under the auspices of the European Cell Biology Organization. 2004;96:631–637. doi: 10.1016/j.biolcel.2004.06.003. [DOI] [PubMed] [Google Scholar]
  34. Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, Ellenberg J, Panier S, Durocher D, Bartek J, et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell. 2009;136:435–446. doi: 10.1016/j.cell.2008.12.041. [DOI] [PubMed] [Google Scholar]
  35. Douglas P, Zhong J, Ye R, Moorhead GB, Xu X, Lees-Miller SP. Protein phosphatase 6 interacts with the DNA-dependent protein kinase catalytic subunit and dephosphorylates gamma-H2AX. Molecular and cellular biology. 2010;30:1368–1381. doi: 10.1128/MCB.00741-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Dulic V, Stein GH, Far DF, Reed SI. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Molecular and cellular biology. 1998;18:546–557. doi: 10.1128/mcb.18.1.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Dumaz N, Milne DM, Meek DW. Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS letters. 1999;463:312–316. doi: 10.1016/s0014-5793(99)01647-6. [DOI] [PubMed] [Google Scholar]
  38. Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–365. doi: 10.1038/ng1093. [DOI] [PubMed] [Google Scholar]
  39. Elgin SC. Heterochromatin and gene regulation in Drosophila. Current opinion in genetics & development. 1996;6:193–202. doi: 10.1016/s0959-437x(96)80050-5. [DOI] [PubMed] [Google Scholar]
  40. Elia MC, Bradley MO. Influence of chromatin structure on the induction of DNA double strand breaks by ionizing radiation. Cancer research. 1992;52:1580–1586. [PubMed] [Google Scholar]
  41. Everett AD. Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart. Dev Dyn. 2001;222:450–458. doi: 10.1002/dvdy.1204. [DOI] [PubMed] [Google Scholar]
  42. Everett AD, Stoops T, McNamara CA. Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells. J Biol Chem. 2001;276:37564–37568. doi: 10.1074/jbc.M105109200. [DOI] [PubMed] [Google Scholar]
  43. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1989;57:1083–1093. doi: 10.1016/0092-8674(89)90045-7. [DOI] [PubMed] [Google Scholar]
  44. Fischer JJ, Toedling J, Krueger T, Schueler M, Huber W, Sperling S. Combinatorial effects of four histone modifications in transcription and differentiation. Genomics. 2008;91:41–51. doi: 10.1016/j.ygeno.2007.08.010. [DOI] [PubMed] [Google Scholar]
  45. Francoz S, Froment P, Bogaerts S, De Clercq S, Maetens M, Doumont G, Bellefroid E, Marine JC. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:3232–3237. doi: 10.1073/pnas.0508476103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Friedberg EC, McDaniel LD, Schultz RA. The role of endogenous and exogenous DNA damage and mutagenesis. Current opinion in genetics & development. 2004;14:5–10. doi: 10.1016/j.gde.2003.11.001. [DOI] [PubMed] [Google Scholar]
  47. Giono LE, Manfredi JJ. The p53 tumor suppressor participates in multiple cell cycle checkpoints. Journal of cellular physiology. 2006;209:13–20. doi: 10.1002/jcp.20689. [DOI] [PubMed] [Google Scholar]
  48. Green CM, Almouzni G. When repair meets chromatin. First in series on chromatin dynamics. EMBO reports. 2002;3:28–33. doi: 10.1093/embo-reports/kvf005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Green DR, Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature. 2009;458:1127–1130. doi: 10.1038/nature07986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Griffiths GJ, Dubrez L, Morgan CP, Jones NA, Whitehouse J, Corfe BM, Dive C, Hickman JA. Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. The Journal of cell biology. 1999;144:903–914. doi: 10.1083/jcb.144.5.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Groth A, Rocha W, Verreault A, Almouzni G. Chromatin challenges during DNA replication and repair. Cell. 2007;128:721–733. doi: 10.1016/j.cell.2007.01.030. [DOI] [PubMed] [Google Scholar]
  52. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nature reviews Cancer. 2002;2:331–341. doi: 10.1038/nrc795. [DOI] [PubMed] [Google Scholar]
  53. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805–816. doi: 10.1016/0092-8674(93)90499-g. [DOI] [PubMed] [Google Scholar]
  54. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. The New England journal of medicine. 1993;329:1318–1327. doi: 10.1056/NEJM199310283291807. [DOI] [PubMed] [Google Scholar]
  55. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299. doi: 10.1038/387296a0. [DOI] [PubMed] [Google Scholar]
  56. Heo K, Kim H, Choi SH, Choi J, Kim K, Gu J, Lieber MR, Yang AS, An W. FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16. Molecular cell. 2008;30:86–97. doi: 10.1016/j.molcel.2008.02.029. [DOI] [PubMed] [Google Scholar]
  57. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic acids research. 1994;22:3551–3555. [PMC free article] [PubMed] [Google Scholar]
  58. Hu J, Yao H, Gan F, Tokarski A, Wang Y. Interaction of OKL38 and p53 in regulating mitochondrial structure and function. PloS one. 2012;7:e43362. doi: 10.1371/journal.pone.0043362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T, et al. p53 is regulated by the lysine demethylase LSD1. Nature. 2007;449:105–108. doi: 10.1038/nature06092. [DOI] [PubMed] [Google Scholar]
  60. Huen MS, Huang J, Leung JW, Sy SM, Leung KM, Ching YP, Tsao SW, Chen J. Regulation of chromatin architecture by the PWWP domain-containing DNA damage-responsive factor EXPAND1/MUM1. Molecular cell. 2010;37:854–864. doi: 10.1016/j.molcel.2009.12.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Huyen Y, Zgheib O, Ditullio RA, Jr, Gorgoulis VG, Zacharatos P, Petty TJ, Sheston EA, Mellert HS, Stavridi ES, Halazonetis TD. Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature. 2004;432:406–411. doi: 10.1038/nature03114. [DOI] [PubMed] [Google Scholar]
  62. Iacovoni JS, Caron P, Lassadi I, Nicolas E, Massip L, Trouche D, Legube G. High-resolution profiling of gammaH2AX around DNA double strand breaks in the mammalian genome. The EMBO journal. 2010;29:1446–1457. doi: 10.1038/emboj.2010.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Ikura T, Tashiro S, Kakino A, Shima H, Jacob N, Amunugama R, Yoder K, Izumi S, Kuraoka I, Tanaka K, et al. DNA damage-dependent acetylation and ubiquitination of H2AX enhances chromatin dynamics. Molecular and cellular biology. 2007;27:7028–7040. doi: 10.1128/MCB.00579-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–1080. doi: 10.1126/science.1063127. [DOI] [PubMed] [Google Scholar]
  65. Kashiwaba S, Kitahashi K, Watanabe T, Onoda F, Ohtsu M, Murakami Y. The mammalian INO80 complex is recruited to DNA damage sites in an ARP8 dependent manner. Biochemical and biophysical research communications. 2010;402:619–625. doi: 10.1016/j.bbrc.2010.10.066. [DOI] [PubMed] [Google Scholar]
  66. Kennedy RD, D’Andrea AD. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24:3799–3808. doi: 10.1200/JCO.2005.05.4171. [DOI] [PubMed] [Google Scholar]
  67. Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Molecular cell. 2009;36:487–499. doi: 10.1016/j.molcel.2009.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Kim JY, Kee HJ, Choe NW, Kim SM, Eom GH, Baek HJ, Kook H, Kook H, Seo SB. Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity. Molecular and cellular biology. 2008;28:2023–2034. doi: 10.1128/MCB.02130-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kishima Y, Yamamoto H, Izumoto Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Ito H, Yoshizaki K, Nakamura H. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem. 2002;277:10315–10322. doi: 10.1074/jbc.M111122200. [DOI] [PubMed] [Google Scholar]
  70. Kitayama K, Kamo M, Oma Y, Matsuda R, Uchida T, Ikura T, Tashiro S, Ohyama T, Winsor B, Harata M. The human actin-related protein hArp5: nucleo-cytoplasmic shuttling and involvement in DNA repair. Experimental cell research. 2009;315:206–217. doi: 10.1016/j.yexcr.2008.10.028. [DOI] [PubMed] [Google Scholar]
  71. Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, Panier S, Mendez M, Wildenhain J, Thomson TM, et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science. 2007;318:1637–1640. doi: 10.1126/science.1150034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Kornberg RD. Eukaryotic transcriptional control. Trends in cell biology. 1999;9:M46–49. [PubMed] [Google Scholar]
  73. Kouzarides T. Histone methylation in transcriptional control. Current opinion in genetics & development. 2002;12:198–209. doi: 10.1016/s0959-437x(02)00287-3. [DOI] [PubMed] [Google Scholar]
  74. Kraus WL. Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation. Current opinion in cell biology. 2008;20:294–302. doi: 10.1016/j.ceb.2008.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Krishnakumar R, Kraus WL. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Molecular cell. 2010;39:8–24. doi: 10.1016/j.molcel.2010.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137:609–622. doi: 10.1016/j.cell.2009.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, Xi Y, Park BH, Shi X, Garcia BA, et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Molecular cell. 2011;44:609–620. doi: 10.1016/j.molcel.2011.08.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 1998;20:615–626. doi: 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  79. Laguri C, Duband-Goulet I, Friedrich N, Axt M, Belin P, Callebaut I, Gilquin B, Zinn-Justin S, Couprie J. Human mismatch repair protein MSH6 contains a PWWP domain that targets double stranded DNA. Biochemistry. 2008;47:6199–6207. doi: 10.1021/bi7024639. [DOI] [PubMed] [Google Scholar]
  80. Lakin ND, Hann BC, Jackson SP. The ataxia-telangiectasia related protein ATR mediates DNA-dependent phosphorylation of p53. Oncogene. 1999;18:3989–3995. doi: 10.1038/sj.onc.1202973. [DOI] [PubMed] [Google Scholar]
  81. Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell death and differentiation. 2010;17:86–92. doi: 10.1038/cdd.2009.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nature cell biology. 2004;6:443–450. doi: 10.1038/ncb1123. [DOI] [PubMed] [Google Scholar]
  83. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323–331. doi: 10.1016/s0092-8674(00)81871-1. [DOI] [PubMed] [Google Scholar]
  84. Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Current opinion in genetics & development. 2011;21:175–186. doi: 10.1016/j.gde.2011.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Li M, Brooks CL, Kon N, Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Molecular cell. 2004;13:879–886. doi: 10.1016/s1097-2765(04)00157-1. [DOI] [PubMed] [Google Scholar]
  86. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ, 3rd, Qiao Q, Neubert TA, Xu RM, Gozani O, et al. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. The Journal of biological chemistry. 2009;284:34283–34295. doi: 10.1074/jbc.M109.034462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:9210–9214. doi: 10.1073/pnas.89.19.9210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer research. 2003;63:2596–2605. [PubMed] [Google Scholar]
  89. Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell. 1979;17:43–52. doi: 10.1016/0092-8674(79)90293-9. [DOI] [PubMed] [Google Scholar]
  90. Liu Y, Kulesz-Martin M. p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis. 2001;22:851–860. doi: 10.1093/carcin/22.6.851. [DOI] [PubMed] [Google Scholar]
  91. Llano M, Delgado S, Vanegas M, Poeschla EM. Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase. J Biol Chem. 2004;279:55570–55577. doi: 10.1074/jbc.M408508200. [DOI] [PubMed] [Google Scholar]
  92. Lopez-Girona A, Kanoh J, Russell P. Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast. Current biology : CB. 2001;11:50–54. doi: 10.1016/s0960-9822(00)00026-9. [DOI] [PubMed] [Google Scholar]
  93. Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Celeste A, Manis JP, van Deursen J, Nussenzweig A, Paull TT, et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Molecular cell. 2006;21:187–200. doi: 10.1016/j.molcel.2005.11.025. [DOI] [PubMed] [Google Scholar]
  94. Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair? Nature reviews Molecular cell biology. 2012;13:436–447. doi: 10.1038/nrm3382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389:251–260. doi: 10.1038/38444. [DOI] [PubMed] [Google Scholar]
  96. Lukas J, Lukas C, Bartek J. More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance. Nature cell biology. 2011;13:1161–1169. doi: 10.1038/ncb2344. [DOI] [PubMed] [Google Scholar]
  97. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem. 2003;278:33528–33539. doi: 10.1074/jbc.M303594200. [DOI] [PubMed] [Google Scholar]
  98. Marango J, Shimoyama M, Nishio H, Meyer JA, Min DJ, Sirulnik A, Martinez-Martinez Y, Chesi M, Bergsagel PL, Zhou MM, et al. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood. 2008;111:3145–3154. doi: 10.1182/blood-2007-06-092122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007;316:1160–1166. doi: 10.1126/science.1140321. [DOI] [PubMed] [Google Scholar]
  100. Maurer-Stroh S, Dickens NJ, Hughes-Davies L, Kouzarides T, Eisenhaber F, Ponting CP. The Tudor domain ‘Royal Family’: Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem Sci. 2003;28:69–74. doi: 10.1016/S0968-0004(03)00004-5. [DOI] [PubMed] [Google Scholar]
  101. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nature reviews Cancer. 2009;9:714–723. doi: 10.1038/nrc2716. [DOI] [PubMed] [Google Scholar]
  102. Mello JA, Sillje HH, Roche DM, Kirschner DB, Nigg EA, Almouzni G. Human Asf1 and CAF-1 interact and synergize in a repair-coupled nucleosome assembly pathway. EMBO reports. 2002;3:329–334. doi: 10.1093/embo-reports/kvf068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Meulmeester E, Pereg Y, Shiloh Y, Jochemsen AG. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle. 2005;4:1166–1170. doi: 10.4161/cc.4.9.1981. [DOI] [PubMed] [Google Scholar]
  104. Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S, Jackson SP. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nature structural & molecular biology. 2010;17:1144–1151. doi: 10.1038/nsmb.1899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Misteli T, Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nature reviews Molecular cell biology. 2009;10:243–254. doi: 10.1038/nrm2651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Moon SH, Nguyen TA, Darlington Y, Lu X, Donehower LA. Dephosphorylation of gamma-H2AX by WIP1: an important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle. 2010;9:2092–2096. doi: 10.4161/cc.9.11.11810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY, Eppink B, Chung YM, Shalev G, Shema E, et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Molecular cell. 2011;41:529–542. doi: 10.1016/j.molcel.2011.02.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Murr R, Loizou JI, Yang YG, Cuenin C, Li H, Wang ZQ, Herceg Z. Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks. Nature cell biology. 2006;8:91–99. doi: 10.1038/ncb1343. [DOI] [PubMed] [Google Scholar]
  109. Nathan D, Ingvarsdottir K, Sterner DE, Bylebyl GR, Dokmanovic M, Dorsey JA, Whelan KA, Krsmanovic M, Lane WS, Meluh PB, et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 2006;20:966–976. doi: 10.1101/gad.1404206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Ng JM, Vermeulen W, van der Horst GT, Bergink S, Sugasawa K, Vrieling H, Hoeijmakers JH. A novel regulation mechanism of DNA repair by damage-induced and RAD23-dependent stabilization of xeroderma pigmentosum group C protein. Genes Dev. 2003;17:1630–1645. doi: 10.1101/gad.260003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature. 2009;460:287–291. doi: 10.1038/nature08086. [DOI] [PubMed] [Google Scholar]
  112. Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 2004;20:214–220. doi: 10.1016/j.tig.2004.02.007. [DOI] [PubMed] [Google Scholar]
  113. Okuda Y, Nakamura H, Yoshida K, Enomoto H, Uyama H, Hirotani T, Funamoto M, Ito H, Everett AD, Hada T, et al. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci. 2003;94:1034–1041. doi: 10.1111/j.1349-7006.2003.tb01397.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Orphanides G, LeRoy G, Chang CH, Luse DS, Reinberg D. FACT, a factor that facilitates transcript elongation through nucleosomes. Cell. 1998;92:105–116. doi: 10.1016/s0092-8674(00)80903-4. [DOI] [PubMed] [Google Scholar]
  115. Pei H, Zhang L, Luo K, Qin Y, Chesi M, Fei F, Bergsagel PL, Wang L, You Z, Lou Z. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature. 2011;470:124–128. doi: 10.1038/nature09658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Peng G, Yim EK, Dai H, Jackson AP, Burgt I, Pan MR, Hu R, Li K, Lin SY. BRIT1/MCPH1 links chromatin remodelling to DNA damage response. Nature cell biology. 2009;11:865–872. doi: 10.1038/ncb1895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 2011;25:409–433. doi: 10.1101/gad.2021311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Postel-Vinay S, Vanhecke E, Olaussen KA, Lord CJ, Ashworth A, Soria JC. The potential of exploiting DNA-repair defects for optimizing lung cancer treatment. Nature reviews Clinical oncology. 2012;9:144–155. doi: 10.1038/nrclinonc.2012.3. [DOI] [PubMed] [Google Scholar]
  119. Pradeepa MM, Sutherland HG, Ule J, Grimes GR, Bickmore WA. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS genetics. 2012;8:e1002717. doi: 10.1371/journal.pgen.1002717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Price BD, D’Andrea AD. Chromatin remodeling at DNA double-strand breaks. Cell. 2013;152:1344–1354. doi: 10.1016/j.cell.2013.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Prives C, Manfredi JJ. The continuing saga of p53--more sleepless nights ahead. Molecular cell. 2005;19:719–721. doi: 10.1016/j.molcel.2005.08.024. [DOI] [PubMed] [Google Scholar]
  122. Qiu Y, Zhang W, Zhao C, Wang Y, Wang W, Zhang J, Zhang Z, Li G, Shi Y, Tu X, et al. Solution structure of the Pdp1 PWWP domain reveals its unique binding sites for methylated H4K20 and DNA. The Biochemical journal. 2012;442:527–538. doi: 10.1042/BJ20111885. [DOI] [PubMed] [Google Scholar]
  123. Robinson PJ, An W, Routh A, Martino F, Chapman L, Roeder RG, Rhodes D. 30 nm chromatin fibre decompaction requires both H4-K16 acetylation and linker histone eviction. Journal of molecular biology. 2008;381:816–825. doi: 10.1016/j.jmb.2008.04.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Robinson PJ, Fairall L, Huynh VA, Rhodes D. EM measurements define the dimensions of the “30-nm” chromatin fiber: evidence for a compact, interdigitated structure. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:6506–6511. doi: 10.1073/pnas.0601212103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. The Journal of cell biology. 1999;146:905–916. doi: 10.1083/jcb.146.5.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. The Journal of biological chemistry. 1998;273:5858–5868. doi: 10.1074/jbc.273.10.5858. [DOI] [PubMed] [Google Scholar]
  127. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998;12:2831–2841. doi: 10.1101/gad.12.18.2831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, Jackson SP. Human CtIP promotes DNA end resection. Nature. 2007;450:509–514. doi: 10.1038/nature06337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Savic V, Sanborn KB, Orange JS, Bassing CH. Chipping away at gamma-H2AX foci. Cell Cycle. 2009a;8:3285–3290. doi: 10.4161/cc.8.20.9719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Savic V, Yin B, Maas NL, Bredemeyer AL, Carpenter AC, Helmink BA, Yang-Iott KS, Sleckman BP, Bassing CH. Formation of dynamic gamma-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Molecular cell. 2009b;34:298–310. doi: 10.1016/j.molcel.2009.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Schotta G, Sengupta R, Kubicek S, Malin S, Kauer M, Callen E, Celeste A, Pagani M, Opravil S, De La Rosa-Velazquez IA, et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 2008;22:2048–2061. doi: 10.1101/gad.476008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Seeber A, Hauer M, Gasser SM. Nucleosome remodelers in double-strand break repair. Current opinion in genetics & development. 2013 doi: 10.1016/j.gde.2012.12.008. [DOI] [PubMed] [Google Scholar]
  133. Selvakumaran M, Lin HK, Miyashita T, Wang HG, Krajewski S, Reed JC, Hoffman B, Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene. 1994;9:1791–1798. [PubMed] [Google Scholar]
  134. Sengupta S, Harris CC. p53: traffic cop at the crossroads of DNA repair and recombination. Nature reviews Molecular cell biology. 2005;6:44–55. doi: 10.1038/nrm1546. [DOI] [PubMed] [Google Scholar]
  135. Sharp DA, Kratowicz SA, Sank MJ, George DL. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. The Journal of biological chemistry. 1999;274:38189–38196. doi: 10.1074/jbc.274.53.38189. [DOI] [PubMed] [Google Scholar]
  136. Sherr CJ. G1 phase progression: cycling on cue. Cell. 1994;79:551–555. doi: 10.1016/0092-8674(94)90540-1. [DOI] [PubMed] [Google Scholar]
  137. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000;14:289–300. [PMC free article] [PubMed] [Google Scholar]
  138. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell. 1997;91:325–334. doi: 10.1016/s0092-8674(00)80416-x. [DOI] [PubMed] [Google Scholar]
  139. Shiloh Y, Ziv Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nature reviews Molecular cell biology. 2013;14:197–210. [PubMed] [Google Scholar]
  140. Singh DP, Kimura A, Chylack LT, Jr, Shinohara T. Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing. Gene. 2000;242:265–273. doi: 10.1016/s0378-1119(99)00506-5. [DOI] [PubMed] [Google Scholar]
  141. Smerdon MJ. DNA repair and the role of chromatin structure. Current opinion in cell biology. 1991;3:422–428. doi: 10.1016/0955-0674(91)90069-b. [DOI] [PubMed] [Google Scholar]
  142. Smerdon MJ, Tlsty TD, Lieberman MW. Distribution of ultraviolet-induced DNA repair synthesis in nuclease sensitive and resistant regions of human chromatin. Biochemistry. 1978;17:2377–2386. doi: 10.1021/bi00605a020. [DOI] [PubMed] [Google Scholar]
  143. Soria G, Polo SE, Almouzni G. Prime, repair, restore: the active role of chromatin in the DNA damage response. Molecular cell. 2012;46:722–734. doi: 10.1016/j.molcel.2012.06.002. [DOI] [PubMed] [Google Scholar]
  144. St Clair S, Giono L, Varmeh-Ziaie S, Resnick-Silverman L, Liu WJ, Padi A, Dastidar J, DaCosta A, Mattia M, Manfredi JJ. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter. Molecular cell. 2004;16:725–736. doi: 10.1016/j.molcel.2004.11.002. [DOI] [PubMed] [Google Scholar]
  145. Stec I, Nagl SB, van Ommen GJ, den Dunnen JT. The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett. 2000;473:1–5. doi: 10.1016/s0014-5793(00)01449-6. [DOI] [PubMed] [Google Scholar]
  146. Stec I, Wright TJ, van Ommen GJ, de Boer PA, van Haeringen A, Moorman AF, Altherr MR, den Dunnen JT. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Human molecular genetics. 1998;7:1071–1082. doi: 10.1093/hmg/7.7.1071. [DOI] [PubMed] [Google Scholar]
  147. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005;123:1213–1226. doi: 10.1016/j.cell.2005.09.038. [DOI] [PubMed] [Google Scholar]
  148. Sugasawa K, Okuda Y, Saijo M, Nishi R, Matsuda N, Chu G, Mori T, Iwai S, Tanaka K, Tanaka K, et al. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell. 2005;121:387–400. doi: 10.1016/j.cell.2005.02.035. [DOI] [PubMed] [Google Scholar]
  149. Sulli G, Di Micco R, d’Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nature reviews Cancer. 2012;12:709–720. doi: 10.1038/nrc3344. [DOI] [PubMed] [Google Scholar]
  150. Sun Y, Jiang X, Chen S, Fernandes N, Price BD. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:13182–13187. doi: 10.1073/pnas.0504211102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Sy SM, Chen J, Huen MS. The 53BP1-EXPAND1 connection in chromatin structure regulation. Nucleus. 2010;1:472–474. doi: 10.4161/nucl.1.6.13059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annual review of genetics. 2011;45:247–271. doi: 10.1146/annurev-genet-110410-132435. [DOI] [PubMed] [Google Scholar]
  153. Tang J, Qu LK, Zhang J, Wang W, Michaelson JS, Degenhardt YY, El-Deiry WS, Yang X. Critical role for Daxx in regulating Mdm2. Nature cell biology. 2006a;8:855–862. doi: 10.1038/ncb1442. [DOI] [PubMed] [Google Scholar]
  154. Tang W, Willers H, Powell SN. p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts. Cancer research. 1999;59:2562–2565. [PubMed] [Google Scholar]
  155. Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Molecular cell. 2006b;24:827–839. doi: 10.1016/j.molcel.2006.11.021. [DOI] [PubMed] [Google Scholar]
  156. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell. 2008;133:612–626. doi: 10.1016/j.cell.2008.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, Poeschla E. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J Cell Sci. 2005;118:1733–1743. doi: 10.1242/jcs.02299. [DOI] [PubMed] [Google Scholar]
  158. Vempati RK, Jayani RS, Notani D, Sengupta A, Galande S, Haldar D. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. The Journal of biological chemistry. 2010;285:28553–28564. doi: 10.1074/jbc.M110.149393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Vezzoli A, Bonadies N, Allen MD, Freund SM, Santiveri CM, Kvinlaug BT, Huntly BJ, Gottgens B, Bycroft M. Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1. Nat Struct Mol Biol. 2010;17:617–619. doi: 10.1038/nsmb.1797. [DOI] [PubMed] [Google Scholar]
  160. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310. doi: 10.1038/35042675. [DOI] [PubMed] [Google Scholar]
  161. Wang H, Jurado KA, Wu X, Shun MC, Li X, Ferris AL, Smith SJ, Patel PA, Fuchs JR, Cherepanov P, et al. HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor. Nucleic acids research. 2012 doi: 10.1093/nar/gks913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Wang Y, Reddy B, Thompson J, Wang H, Noma K, Yates JR, 3rd, Jia S. Regulation of Set9-mediated H4K20 methylation by a PWWP domain protein. Mol Cell. 2009;33:428–437. doi: 10.1016/j.molcel.2009.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 2004;306:279–283. doi: 10.1126/science.1101400. [DOI] [PubMed] [Google Scholar]
  164. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–730. doi: 10.1126/science.1059108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Wood JL, Singh N, Mer G, Chen J. MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage. The Journal of biological chemistry. 2007;282:35416–35423. doi: 10.1074/jbc.M705245200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Wu H, Zeng H, Lam R, Tempel W, Amaya MF, Xu C, Dombrovski L, Qiu W, Wang Y, Min J. Structural and histone binding ability characterizations of human PWWP domains. PloS one. 2011;6:e18919. doi: 10.1371/journal.pone.0018919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Wu X, Bayle JH, Olson D, Levine AJ. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993;7:1126–1132. doi: 10.1101/gad.7.7a.1126. [DOI] [PubMed] [Google Scholar]
  168. Xiao A, Li H, Shechter D, Ahn SH, Fabrizio LA, Erdjument-Bromage H, Ishibe-Murakami S, Wang B, Tempst P, Hofmann K, et al. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature. 2009;457:57–62. doi: 10.1038/nature07668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Xu Y, Ayrapetov MK, Xu C, Gursoy-Yuzugullu O, Hu Y, Price BD. Histone H2A.Z controls a critical chromatin remodeling step required for DNA double-strand break repair. Molecular cell. 2012;48:723–733. doi: 10.1016/j.molcel.2012.09.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Yang J, Everett AD. Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain. BMC Mol Biol. 2007;8:101. doi: 10.1186/1471-2199-8-101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Yang J, Everett AD. Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein. J Mol Biol. 2009;386:938–950. doi: 10.1016/j.jmb.2008.12.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Yokoyama A, Cleary ML. Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer cell. 2008;14:36–46. doi: 10.1016/j.ccr.2008.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Yoon D, Wang Y, Stapleford K, Wiesmuller L, Chen J. P53 inhibits strand exchange and replication fork regression promoted by human Rad51. Journal of molecular biology. 2004;336:639–654. doi: 10.1016/j.jmb.2003.12.050. [DOI] [PubMed] [Google Scholar]
  174. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Molecular cell. 2001;7:673–682. doi: 10.1016/s1097-2765(01)00213-1. [DOI] [PubMed] [Google Scholar]
  175. Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace AJ., Jr Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 1999;18:2892–2900. doi: 10.1038/sj.onc.1202667. [DOI] [PubMed] [Google Scholar]
  176. Zhu Y, Alvarez C, Doll R, Kurata H, Schebye XM, Parry D, Lees E. Intra-S-phase checkpoint activation by direct CDK2 inhibition. Molecular and cellular biology. 2004;24:6268–6277. doi: 10.1128/MCB.24.14.6268-6277.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Ziegler M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. European journal of biochemistry/FEBS. 2000;267:1550–1564. doi: 10.1046/j.1432-1327.2000.01187.x. [DOI] [PubMed] [Google Scholar]

RESOURCES